{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:04:36Z","timestamp":1790078676848,"version":"4.0.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH123396"],"award-info":[{"award-number":["R01 MH123396"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24 167805"],"award-info":[{"award-number":["K24 167805"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Among underserved people with HIV with a median of one year of long-acting cabotegravir-rilpivirine use, including those starting with viremia due to adherence challenges, we found higher satisfaction and lower treatment burden compared to daily oral ART, although nearly half preferred another dosing modality and\/or a longer dosing interval.<\/jats:p>","DOI":"10.1093\/ofid\/ofag559","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:43:59Z","timestamp":1789213439000},"source":"Crossref","is-referenced-by-count":0,"title":["Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-2191","authenticated-orcid":false,"given":"Katerina A","family":"Christopoulos","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]},{"name":"Department of Medicine, University of Illinois Chicago , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6074-2199","authenticated-orcid":false,"given":"Alex","family":"Beckert","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College Department of Medicine, , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"McCracken","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis Department of Medicine, , St. Louis, Missouri ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylin","family":"Dance","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Ponce De Leon Center, Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3707-1679","authenticated-orcid":false,"given":"Sophie","family":"Plotkin","sequence":"additional","affiliation":[{"name":"University of Chicago Department of Medicine, , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren F","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Ponce De Leon Center, Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-254X","authenticated-orcid":false,"given":"Moira C","family":"McNulty","sequence":"additional","affiliation":[{"name":"University of Chicago Department of Medicine, , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Hickey","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-2804","authenticated-orcid":false,"given":"Mallory O","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-365X","authenticated-orcid":false,"given":"Aaloke","family":"Mody","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis Department of Medicine, , St. Louis, Missouri ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-0321","authenticated-orcid":false,"given":"Xavier A","family":"Erguera","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A","family":"Koester","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-4347","authenticated-orcid":false,"given":"Geoffroy","family":"Liegeon","sequence":"additional","affiliation":[{"name":"University of Chicago Department of Medicine, , Chicago, Illinois ,","place":["USA"]},{"name":"Department of Infectious Diseases, Assistance Publique - H\u00f4pitaux de Paris, Saint-Louis and Lariboisi\u00e8re Hospitals, Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-4198","authenticated-orcid":false,"given":"Jorge","family":"Salazar","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-0794","authenticated-orcid":false,"given":"Jose","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Grochowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-5486","authenticated-orcid":false,"given":"Samantha E","family":"Dilworth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-9123","authenticated-orcid":false,"given":"Torsten B","family":"Neilands","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, California ,","place":["USA"]},{"name":"RTI International , Research Triangle Park, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Colasanti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Ponce De Leon Center, Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026092207161323600_ofag559-B1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QAI.0000000000003500","article-title":"Acceptability of long-acting cabotegravir + rilpivirine in a large, urban, ambulatory HIV clinic","volume":"97","author":"Luc","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026092207161323600_ofag559-B2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1023\/A:1013050904635","article-title":"Validation of the HIV treatment satisfaction questionnaire (HIVTSQ)","volume":"10","author":"Woodcock","year":"2001","journal-title":"Qual Life Res"},{"key":"2026092207161323600_ofag559-B3","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf220","article-title":"Clinical outcomes and perspectives of people with human immunodeficiency virus type 1 twelve months after initiation of long-acting cabotegravir and rilpivirine in an observational real-world US study (BEYOND)","volume":"12","author":"Dandachi","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026092207161323600_ofag559-B4","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.70082","article-title":"Optimizing the patient journey: insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan white-funded clinics in the United States","volume":"29","author":"Erguera","year":"2026","journal-title":"J Int AIDS Soc"},{"key":"2026092207161323600_ofag559-B5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1524-4733.2006.00121.x","article-title":"Validation of the revised 10-item HIV treatment satisfaction questionnaire status version and new change version","volume":"9","author":"Woodcock","year":"2006","journal-title":"Value Health"},{"key":"2026092207161323600_ofag559-B6","doi-asserted-by":"crossref","first-page":"A420","DOI":"10.1016\/j.jval.2016.09.426","article-title":"Psychometric evaluation of the revised HIV Treatment Satisfaction Questionnaire (HIVTSQ)","volume":"19","author":"Romaine","year":"2016","journal-title":"Value Health"},{"key":"2026092207161323600_ofag559-B7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1741-7015-12-109","article-title":"Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform","volume":"12","author":"Tran","year":"2014","journal-title":"BMC Med"},{"key":"2026092207161323600_ofag559-B8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.311.6996.42","article-title":"Qualitative research: reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research","volume":"311","author":"Pope","year":"1995","journal-title":"BMJ"},{"key":"2026092207161323600_ofag559-B9","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1007\/s10461-020-02929-8","article-title":"Patient-reported outcomes in ATLAS and FLAIR participants on long-acting regimens of cabotegravir and rilpivirine over 48 weeks","volume":"24","author":"Murray","year":"2020","journal-title":"AIDS Behav"},{"key":"2026092207161323600_ofag559-B10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40271-021-00524-0","article-title":"Patient-reported outcomes through 1 year of an HIV-1 clinical trial evaluating long-acting cabotegravir and rilpivirine administered every 4 or 8 weeks (ATLAS-2 M)","volume":"14","author":"Chounta","year":"2021","journal-title":"Patient"},{"key":"2026092207161323600_ofag559-B11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/hiv.70058","article-title":"Patient-reported outcomes in clinical trials assessing the effectiveness of cabotegravir+rilpivirine long-acting injections as antiretroviral therapy: a systematic review","volume":"26","author":"Vinay","year":"2025","journal-title":"HIV Med"},{"key":"2026092207161323600_ofag559-B12","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26394","article-title":"Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir\/rilpivirine among early adopters in three U. S. clinics","volume":"27","author":"Christopoulos","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2026092207161323600_ofag559-B13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2803","article-title":"We need minimally disruptive medicine","volume":"339","author":"May","year":"2009","journal-title":"BMJ"},{"key":"2026092207161323600_ofag559-B14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/infdis\/jiaf159","article-title":"Lenacapavir plus 2 broadly neutralizing antibodies, teropavimab and zinlirvimab, for people with HIV-1 highly susceptible to either teropavimab or zinlirvimab","volume":"231","author":"Eron","year":"2025","journal-title":"J Infect Dis"},{"key":"2026092207161323600_ofag559-B15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf600","article-title":"Discontinuation of long-acting injectable cabotegravir\u2013rilpivirine in a large clinic cohort","volume":"12","author":"Christopoulos","year":"2025","journal-title":"Open Forum Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag559\/71222999\/ofag559.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag559\/71222999\/ofag559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag559\/71222999\/ofag559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:16:21Z","timestamp":1790075781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag559\/8817061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag559","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"ofag559"}}